The development of invasive candidiasis and candidiasis-related death.

Probability of the development of invasive candidiasis (bloodstream and tissue infection, solid lines) and candidiasis-related death (dashed lines) in placebo recipients and fluconazole (fluc) recipients. Compared with fluconazole recipients, more patients in the placebo arm had candidal infection (20% vs 3%,P < .001) and candidiasis-related death (14% vs 1%,P < .001). Also presented is the duration of fluconazole administered (conditioning through day 75, bold line).